Suchergebnisse - "Yeh, Teng-Kuang"

PubPharm (8)

1

Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer

enthalten in: Journal of medicinal chemistry | 2023

von Li, M. | Coumar, M. | Lin, S. | +16

2

Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC Oncoproteins

enthalten in: Journal of medicinal chemistry | 2021

von Chi, Y. | Yeh, T. | Ke, Y. | +17

3

Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia

enthalten in: Journal of medicinal chemistry | 2019

von Lin, W. | Wu, S. | Yeh, T. | +25

4

Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer

enthalten in: Journal of medicinal chemistry | 2019

von Lin, S. | Chang Hsu, Y. | Peng, Y. | +17

5

Synthesis and evaluation of novel 7H-pyrrolo-[2,3-d]pyrimidine derivatives as potential anticancer agents

enthalten in: Future medicinal chemistry | 2019

von Liu, Y. | Chen, C. | Yeh, T. | +1

6

Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants

enthalten in: Journal of medicinal chemistry | 2019

von Wu, T. | Lin, W. | Tsai, H. | +18

7

BPR1K653, a novel Aurora kinase inhibitor, exhibits potent anti-proliferative activity in MDR1 (P-gp170)-mediated multidrug-resistant cancer cells

enthalten in: PloS one | 2011

von Cheung, C. | Lin, W. | Hsu, J. | +11

8

Design and synthesis of tetrahydropyridothieno[2,3-d]pyrimidine scaffold based epidermal growth factor receptor (EGFR) kinase inhibitors : the role of side chain chirality and Michael acceptor group for maximal potency

enthalten in: Journal of medicinal chemistry | 2010

von Wu, C. | Coumar, M. | Chu, C. | +20

1
[1]